期刊文献+

乙二胺改性聚乳酸溶液的性质 被引量:2

Characteristics of EMPLA in Tetrahydrofuran(THF) by GPC-MALLS
下载PDF
导出
摘要 乙二胺改性聚乳酸(EMPLA)是一种具有支化结构的新型生物材料。文中采用GPC-MALLS技术对其在四氢呋喃(THF)中的分子量、分子量分布、半径、支化及其这些量之间的相互关系进行了分析与研究,结果表明:乙二胺改性聚乳酸在四氢呋喃中的折光指数增量dn/dc值为0.052 mL/g,第二维利系数A2为3.905e-3 mol mL/g2,重均分子量-Mw为5.753e+4,重均均方根旋转半径Rw为4.5 nm,-Mw与Rw的关系式为:Rw=0.608×-Mw0.316,通过与线性聚乳酸(PDLLA)的比较,能够得到具有与PDLLA相同分子量的EMPLA有较小的均方根旋转半径的结论,并能够推出EMPLA在四氢呋喃溶液中的分子构象为球形。 Ethylenediamine-modified polylactic acid (EMPLA) is a newly synthesized polymer, the Mw, size distribution and branching property of EMPLA were analyzed by GPC-MALLS detector technology and The results show: the dn/dc value is 0.052 mL/g, the A2 value is 3.905e - 3 mol mL/g^2, the -Mw is 5.753e+4, the Rw is 4.5 nm, and the relation of Rw and Mw is Rw=0.608 Mw^0.316,. By comparing to the linear PDLLA polymer, the branched one has a shorter RMS radius, and whose conformation in THF is inferred to be spherical shape.
出处 《高分子材料科学与工程》 EI CAS CSCD 北大核心 2008年第10期79-82,共4页 Polymer Materials Science & Engineering
基金 国家自然科学基金资助项目(30470474) 高等学校重点实验室访问学者基金资助
关键词 乙二胺改性聚乳酸 GPC/MALLS 分子表征 支化 EMPLA GPC/MALLS molecular token branching characteristics
  • 相关文献

参考文献10

  • 1罗彦凤,王远亮,牛旭锋,吴杨兰,潘君,石梁萍.新型改性聚乳酸及其体外生物可降解性研究[J].高技术通讯,2005,15(2):55-59. 被引量:11
  • 2ZIMM B H, GEORGE A. J. Chem. Phys., 1948, 16: 1093-1099.
  • 3WYATT P J. Anal. Chim. Acta, 1993, 272: 1-40.
  • 4KRATOCHVIL P. Elsevier Amsterdam, 1987.
  • 5罗彦凤,王远亮,牛旭锋,吴杨兰,潘君,石梁萍.二胺改性聚乳酸的合成与表征[J].高分子材料科学与工程,2005,21(2):139-142. 被引量:14
  • 6GRCEV S, SCHOENMAKERS P, LEDEMA P. Polymer, 2004, 45: 39-48.
  • 7TERAO K, MAYS J W. European Polymer Journal, 2004, 40: 1623-1627.
  • 8FREDHEIM G E, BRAATEN S M, CHRISTENSEN B E. Journal of Chromatography A, 2002, 942(1-2): 191- 199.
  • 9PODZIMEK S. Journal of Applied Polymer Science, 1994, 54: 91-103.
  • 10XUM, TANK, ZHOU H J, et al. Journal of Functional Polymers, 2003, 16: 299-304.

二级参考文献34

  • 1王勤,路岩,张娟,李凤琴.以聚乳酸为载体的药物释放及动物疗效学的研究[J].中国生物医学工程学报,1995,14(1):11-15. 被引量:9
  • 2奥斯伯F 布冷伦特R 等.精编分子生物学实验指南(第1版)[M].北京:科学出版社,1998.31.
  • 3Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable olMlopaedic implants for internal fixation: a review. Biomaterials, 2000, 21(24): 2615.
  • 4Zhang X C, McAuley K B, Goosen M F A. Towards predication of release profiles of antibiotics from coated poly ( D, L-lactide) cylinders. J Control Release, 1995, 34(2): 175.
  • 5Cima L G, Vacanti J P, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer subswates. J Biomed Eng, 1991, 113:143.
  • 6Meinig R P,Rahn B, Perren S M, et al. Bone regeneration with resorbable polymeric membranes: treament of diaphyseal bone defects in the rabbit radius with poly(L-lactide) membrane. A pilot study. J Oahop Trauma, 1996, 10:178.
  • 7Bergsma J E, Rozema F R, Bos R M, et al. Foreign-body reaction to resorbable poly(I-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures. J Oral Maxillofac Surg, 1993, 51:666.
  • 8Luo Y F, Wang Y L, Pan J, et al. A new family of modified poly(d, 1- lactic acids). Symposium of 11th International conference of Biomedical Engineering (CD edition), 2002,Singapore.
  • 9Hutmacher D W. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J Biomater Sci : Polymer Edn, 2001, 12( 1 ) : 107.
  • 10Middleton J C, Tipton A J. Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 2000, 21:2335.

共引文献21

同被引文献107

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部